AAAAAA
Results:
1-12
|
Results: 12
Authors:
CUMMINGS J
MACPHERSON JS
SMYTH JF
JODRELL DI
Citation: J. Cummings et al., NOVEL MECHANISM OF DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, Annals of oncology, 9, 1998, pp. 234-234
Authors:
MACPHERSON JS
CUMMINGS J
SMYTH JF
JODRELL DI
Citation: Js. Macpherson et al., INVOLVEMENT OF BCL-2 FAMILY MEMBERS IN DRUG-RESISTANCE TO TOPOISOMERASE-I (TOPO-I) INHIBITORS, British Journal of Cancer, 78, 1998, pp. 21-21
Authors:
MACPHERSON JS
CUMMINGS J
MEIKLE I
MILLER EP
SMYTH JF
Citation: Js. Macpherson et al., CELL-CYCLE EFFECTS OF THE NOVEL TOPOISOMERASE-I INHIBITOR NU ICRF-505IN A PANEL OF CHINESE-HAMSTER VARY CELL-LINES/, European journal of cancer, 33(2), 1997, pp. 280-283
Authors:
CUMMINGS J
MEIKLE I
MACPHERSON JS
SMYTH JF
Citation: J. Cummings et al., DETERMINATION OF THE NOVEL TOPOISOMERASE-I INHIBITOR NU ICRF-505 AND ITS MAJOR METABOLITE IN PLASMA, TISSUE AND TUMOR BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY/, Journal of chromatography B. Biomedical applications, 685(1), 1996, pp. 159-164
Authors:
CUMMINGS J
MEIKLE I
MACPHERSON JS
SMYTH JF
Citation: J. Cummings et al., CHARACTERIZATION OF THE MAJOR METABOLITE OF THE NOVEL TOPOISOMERASE-IINHIBITOR NU ICRF-505/, Anti-cancer drug design, 11(5), 1996, pp. 367-382
Authors:
MEIKLE I
CUMMINGS J
MACPHERSON JS
SMYTH JF
Citation: I. Meikle et al., INDUCTION OF APOPTOSIS IN HUMAN CANCER CELL-LINES BY THE NOVEL ANTHRACENYL AMINO-ACID TOPOISOMERASE-I INHIBITOR NU ICRF-505/, British Journal of Cancer, 74(3), 1996, pp. 374-379
Authors:
CUMMINGS J
MACPHERSON JS
MEIKLE I
SMYTH JF
Citation: J. Cummings et al., DEVELOPMENT OF ANTHRACENYL-AMINO ACID CONJUGATES AS TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS THAT CIRCUMVENT DRUG-RESISTANCE, Biochemical pharmacology, 52(7), 1996, pp. 979-990
Authors:
CUMMINGS J
MEIKLE I
MACPHERSON JS
SMYTH JF
Citation: J. Cummings et al., ACCUMULATION OF ANTHRACENYL AMINO-ACID TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS IN DRUG-SENSITIVE AND DRUG-RESISTANT HUMAN OVARIAN-CANCER CELL-LINES DETERMINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 103-109
Authors:
MEIKLE I
CUMMINGS J
MACPHERSON JS
SMYTH JF
Citation: I. Meikle et al., IDENTIFICATION OF ANTHRACENYL-DIPEPTIDE CONJUGATES AS NOVEL TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS AND THEIR EVALUATION AS POTENTIAL ANTICANCER DRUGS, Anti-cancer drug design, 10(7), 1995, pp. 515-527
Authors:
CUMMINGS J
SUMNER AT
SLAVOTINEK A
MEIKLE I
MACPHERSON JS
SMYTH JF
Citation: J. Cummings et al., CYTOGENETIC EVALUATION OF THE MECHANISM OF CELL-DEATH INDUCED BY THE NOVEL ANTHRACENYL-AMINO ACID TOPOISOMERASE-II CATALYTIC INHIBITOR NU ICRF-500/, Mutation research. Genetic toxicology testing, 344(1-2), 1995, pp. 55-62
BIOCHEMISTRY OF TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITION BY ANTHRACENYL-AMINO ACID CONJUGATES
Authors:
MEIKLE I
CUMMINGS J
MACPHERSON JS
HADFIELD JA
SMYTH JF
Citation: I. Meikle et al., BIOCHEMISTRY OF TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITION BY ANTHRACENYL-AMINO ACID CONJUGATES, Biochemical pharmacology, 49(12), 1995, pp. 1747-1757
Authors:
FRENCH RC
CUMMINGS J
MACLELLAN A
MACPHERSON JS
RITCHIE AA
SMYTH JF
Citation: Rc. French et al., THE COMPARATIVE DISPOSITION OF THE PYROLLOQUINONE GR63178A AND ITS 9-HYDROXY METABOLITE GR54374X IN SENSITIVE AND RESISTANT MOUSE COLON ADENOCARCINOMA, Cancer chemotherapy and pharmacology, 32(2), 1993, pp. 156-161
Risultati:
1-12
|